about
Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligandsA nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptorsRegulation of circadian behaviour and metabolism by synthetic REV-ERB agonistsStructure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNANuclear receptors and their selective pharmacologic modulatorsHelix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactionsStructure of REV-ERB Ligand-binding Domain Bound to a Porphyrin AntagonistBroad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and LipogenesisCorrelation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acidsRequirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptorExpression of DAX-1, the gene responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalamic-pituitary-adrenal/gonadal axisIdentification of a putative steroidogenic factor-1 response element in the DAX-1 promoterTherapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of AutismClock genes, pancreatic function, and diabetesRegulation of carbohydrate metabolism by the farnesoid X receptorPharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviourA natural product ligand of the oxysterol receptor, liver X receptor.The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock.Artemisia scoparia enhances adipocyte development and endocrine function in vitro and enhances insulin action in vivoRev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistromeRegulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha.Regulation of adipogenesis by natural and synthetic REV-ERB ligands.Action of RORs and their ligands in (patho)physiology.REV-ERB and ROR nuclear receptors as drug targets.Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB.Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators.Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonistIdentification of a novel non-retinoid pan inverse agonist of the retinoic acid receptorsThe optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetesSuppression of TH17 differentiation and autoimmunity by a synthetic ROR ligandGenetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis.SIRT1 in the Ventromedial Hypothalamus: A Nutrient Sensor Input Into the Internal TimekeeperThe coactivator LXXLL nuclear receptor recognition motif.Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism.
P50
Q24336344-8F017472-AC22-4B33-81B0-3BFDC1C75964Q24563282-B6CBA0A6-48EF-4773-96F8-F0722711442DQ24629345-2F0DE689-29A1-4146-8E67-5279A7CD1758Q24655111-D46159BE-E9BB-4166-8468-1AC3CD57F653Q26825692-37CF1566-BC71-45C3-9DFD-0AB21603D78CQ27642107-E6F0CB2E-D193-4069-91E2-6E7718C29914Q27683978-A4BAAC5A-0C1A-447A-AFC3-D0ED1DB586D3Q28118739-24B5F063-184D-414E-842A-492870AEEF47Q28141468-D4FC3A96-CC80-48A3-94E0-4AB49EC404C2Q28212805-E12CEBD5-9815-41E1-8D68-D54628DA2BD7Q28235867-AEA6DB30-1F3D-457A-937A-863677BE1044Q28275408-19928A0F-B531-4613-91DD-8B49036C0966Q28297581-720D47A4-96A0-4AA0-83D0-6EFDE7A98A8AQ28387385-53EA2EA3-5DED-4299-B549-FC28C68ADCDDQ28393998-7AFCB0C4-B548-4FFA-B32D-605E723C32F9Q28564815-897818BE-B766-46B8-BCD3-D908FE7EB0B0Q30657215-6844326D-C5DC-4830-B5D2-59D6915806CEQ30974044-8D42D1B1-4EBC-487A-A5AC-1D01FC2EAA60Q33613397-C064F247-0CD9-4B9B-91E7-5746F8F6E843Q33642674-15607ADD-1046-47FD-B59F-C87CCF73ACB2Q33733950-24C19401-B094-4049-92F5-D8AB4F429710Q33836033-49E472F1-69E5-4D17-8140-4BFB7A165278Q33855037-F38F534E-90F0-4D96-B38F-EA5C4F0F3606Q33993896-C7B009D1-6C93-4720-A2D2-BCF1123F22CEQ34287702-42434BCF-632B-4D52-9707-EB90A04D2F7DQ34407313-E77DB0E7-25D3-483A-8044-19CC177030BBQ34414231-72F20540-5ECC-4A13-98A8-9517284900CDQ34429173-D3F5BC51-3511-4A99-8A4C-AC50A96C6A25Q34435158-F0F59410-F3D7-4EF6-BCFE-B4E384859F9DQ34587720-81C20FCE-52B2-4C68-B1D3-7879A91116E9Q34700617-13891F76-2F21-4DFB-BA66-BAD2B57C2B3AQ34789625-A6FE5A0B-486F-42E5-95DC-181D1DEF696BQ35053371-FC573B0F-EBD2-442D-9C13-0F22E1A1D797Q35055598-8F8A22C2-8DD5-4D20-BCDF-921AC3D5C053Q35088799-4B138D21-B58E-4B7B-AB47-4DCF2E7EB4DDQ35143424-CCD16CE8-F727-4CAD-A914-47E19EDD483EQ35562552-4D6123FD-098D-4963-94BC-7384B4616CA3Q35603369-DEC63D7A-4EEF-4FB2-BFB0-9FA7C311D887Q35721024-E06ED7DD-4294-4540-A49E-487F664BA207Q35753031-04641B1B-6B0A-47B2-94AC-B8CF1CE7D7F4
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
T P Burris
@ast
T P Burris
@en
T P Burris
@es
T P Burris
@nl
type
label
T P Burris
@ast
T P Burris
@en
T P Burris
@es
T P Burris
@nl
prefLabel
T P Burris
@ast
T P Burris
@en
T P Burris
@es
T P Burris
@nl
P31
P496
0000-0003-2922-4449